Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada
Authors (first, second and last of 15)
Collection
Psoriasis
A collection of recent articles on psoriasis
Articles (59 in this collection)
-
-
Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis
Authors (first, second and last of 4)
-
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Authors (first, second and last of 25)
-
-
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Authors (first, second and last of 12)
-
-
Do Biologic Treatments for Psoriasis Lower the Risk of Psoriatic Arthritis? A Systematic Review
Authors
-
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
Authors (first, second and last of 13)
-
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
Authors (first, second and last of 10)
-
-
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative
Authors (first, second and last of 5)
-
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies
Authors (first, second and last of 6)
-
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
Authors (first, second and last of 14)
-
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review
Authors (first, second and last of 6)
-
-
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
Authors (first, second and last of 36)
-
-
-
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review
Authors (first, second and last of 5)
-
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Authors (first, second and last of 12)
-
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
Authors (first, second and last of 5)
-
-
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review
Authors (first, second and last of 5)
-
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature
Authors (first, second and last of 5)
-
-
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey
Authors (first, second and last of 6)
-
-
-
-
-
-
-
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
Authors (first, second and last of 11)
-
-
-
-
-
Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study
Authors (first, second and last of 7)
-
Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study
Authors (first, second and last of 4)
-
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
Authors (first, second and last of 5)
-
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
Authors (first, second and last of 30)
-
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial
Authors (first, second and last of 5)
-
Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 Patients
Authors (first, second and last of 15)
-
-
-
-
Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection
Authors (first, second and last of 4)
-
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study
Authors (first, second and last of 9)
-
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
Authors (first, second and last of 4)
-
Progress to Date in Advancing Stratified Medicine in Psoriasis
Authors (first, second and last of 4)
